Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
The Lancet. Diabetes & Endocrinology
|
December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
Gary Wittert, Karen Bracken, Kristy P Robledo, et al.
European Journal of Endocrinology
|
December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model
Kristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
Clinical Endocrinology
|
December 21, 2021
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society
Frances Milat, Sabashini K Ramchand, Madhuni Herath, et al.
Clinical Endocrinology
|
December 20, 2021
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society
Julie A Miller, Justin Gundara, Simon Harper, et al.
Parkinsonism & Related Disorders
|
June 20, 2018
Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease
Ai Huey Tan, Yin Cheng Hew, Shen-Yang Lim, et al.
Australasian Journal on Ageing
|
December 8, 2022
The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process
Jesse Zanker, Marc Sim, Kate Anderson, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 9, 2022
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand
Jesse Zanker, Marc Sim, Kate Anderson, et al.
The Lancet. Healthy Longevity
|
June 17, 2022
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
Jemma Hudson, Moira Cruickshank, Richard Quinton, et al.
The Lancet. Healthy Longevity
|
October 7, 2023
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
Jemma Hudson, Moira Cruickshank, Richard Quinton, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
The Lancet. Diabetes & Endocrinology
|
December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
Gary Wittert, Karen Bracken, Kristy P Robledo, et al.
European Journal of Endocrinology
|
December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model
Kristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
Clinical Endocrinology
|
December 21, 2021
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society
Frances Milat, Sabashini K Ramchand, Madhuni Herath, et al.
Clinical Endocrinology
|
December 20, 2021
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society
Julie A Miller, Justin Gundara, Simon Harper, et al.
Parkinsonism & Related Disorders
|
June 20, 2018
Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease
Ai Huey Tan, Yin Cheng Hew, Shen-Yang Lim, et al.
Australasian Journal on Ageing
|
December 8, 2022
The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) sarcopenia diagnosis and management task force: Findings from the consumer expert Delphi process
Jesse Zanker, Marc Sim, Kate Anderson, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 9, 2022
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand
Jesse Zanker, Marc Sim, Kate Anderson, et al.
The Lancet. Healthy Longevity
|
June 17, 2022
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
Jemma Hudson, Moira Cruickshank, Richard Quinton, et al.
The Lancet. Healthy Longevity
|
October 7, 2023
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
Jemma Hudson, Moira Cruickshank, Richard Quinton, et al.
Page
of 19